Published in Circulation on September 16, 1997
Bypass Angioplasty Revascularization Investigation (BARI) | NCT00000462
Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry. JACC Cardiovasc Interv (2008) 1.49
Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells. Diabetes (2006) 1.13
Influence of diabetes mellitus on heart failure risk and outcome. Cardiovasc Diabetol (2003) 1.12
Prevalence and predictors of an abnormal stress myocardial perfusion study in asymptomatic patients with type 2 diabetes mellitus. Eur J Nucl Med Mol Imaging (2008) 0.97
Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein. Diabetologia (2010) 0.94
Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment? Arch Med Sci (2011) 0.94
Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting. Rev Endocr Metab Disord (2010) 0.90
Influence of diabetes on >10-year outcomes after percutaneous coronary intervention. Heart Vessels (2008) 0.88
The CARDia trial protocol. Heart (2003) 0.88
Coronary revascularization in diabetic patients: Current state of evidence. Exp Clin Cardiol (2011) 0.87
Lithium chloride inhibits vascular smooth muscle cell proliferation and migration and alleviates injury-induced neointimal hyperplasia via induction of PGC-1α. PLoS One (2013) 0.85
Clinical review: Screening for coronary artery disease in type 2 diabetes. J Clin Endocrinol Metab (2012) 0.83
Changing outcomes of coronary revascularization in British Columbia, 1995-2001. Can J Cardiol (2006) 0.82
Can cardiac computed tomography predict cardiovascular events in asymptomatic type-2 diabetics?: results of a long term follow-up. BMC Cardiovasc Disord (2014) 0.82
Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials. Cardiovasc Diabetol (2016) 0.82
Comparison of coronary plaque characteristics between diabetic and non-diabetic subjects: An in vivo optical coherence tomography study. Diabetes Res Clin Pract (2008) 0.81
Is the advantage of coronary bypass graft surgery over percutaneous coronary intervention in diabetic patients with severe multivessel disease influenced by the status of insulin requirement? J Geriatr Cardiol (2014) 0.80
Predictors and incidence of stent edge dissections in patients with type 2 diabetes as determined by optical coherence tomography. Int J Cardiovasc Imaging (2013) 0.80
Metformin use in patients with type 2 diabetes mellitus is associated with reduced risk of deep vein thrombosis: a non-randomized, pair-matched cohort study. BMC Cardiovasc Disord (2014) 0.80
A value-based analysis of hemodynamic support strategies for high-risk heart failure patients undergoing a percutaneous coronary intervention. Am Health Drug Benefits (2013) 0.79
Microalbuminuria predicts silent myocardial ischaemia in type 2 diabetes patients. Eur J Nucl Med Mol Imaging (2013) 0.79
Problem of angioplasty in diabetics. Circulation (1997) 0.78
Long-term prognosis of south Asians following acute coronary syndromes. Can J Cardiol (2008) 0.77
Coronary artery disease: revascularization strategies for patients with CAD and diabetes. Nat Rev Cardiol (2010) 0.77
Incremental prognostic value of dobutamine-atropine stress 99mTc-tetrofosmin myocardial perfusion imaging for predicting outcome in diabetic patients with limited exercise capacity. Eur J Nucl Med Mol Imaging (2005) 0.77
Acute Myocardial Infarction Is a Risk Factor for New Onset Diabetes in Patients with Coronary Artery Disease. PLoS One (2015) 0.76
The comparative efficacy of percutaneous and surgical coronary revascularization in 2009: a review. Tex Heart Inst J (2009) 0.76
Coronary artery disease and diabetes mellitus. Cardiol Clin (2014) 0.76
Cardiac risk assessment in asymptomatic diabetes: combining [corrected] different imaging modalities and surrogate markers? J Nucl Cardiol (2011) 0.75
Percutaneous coronary intervention in diabetics: time to consider "intimal remodelling therapy"? Heart (2002) 0.75
The diabetes epidemic and its effect on cardiac surgery practice. J Thorac Cardiovasc Surg (2015) 0.75
Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis. Interact Cardiovasc Thorac Surg (2013) 0.75
Optimal choice of coronary revascularization and stent type in diabetic patients with coronary artery disease. Cardiol Ther (2013) 0.75
Efficacy of Glucose-Insulin-Potassium Infusion on Left Ventricular Performance in Type II Diabetic Patients Undergoing Elective Coronary Artery Bypass Graft.Dy. ARYA Atheroscler (2010) 0.75
Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitus. Curr Opin Pharmacol (2012) 0.75
Stents or surgery: the case for stents. Tex Heart Inst J (2005) 0.75
Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Eur J Heart Fail (2015) 0.75
Analysis of transit time flow of the right internal thoracic artery anastomosed to the left anterior descending artery compared to the left internal thoracic artery. Rev Bras Cir Cardiovasc (2014) 0.75
Management of multivessel coronary disease after primary angioplasty: staged reintervention versus optimized clinical treatment and two-year follow-up. Rev Bras Cir Cardiovasc (2014) 0.75
Assessment of coronary heart diseases in diabetics in al-Madinah al-Munawarah. Int J Gen Med (2012) 0.75
[Arterial grafts in coronary surgery for diabetic patients]. Clin Res Cardiol (2006) 0.75
Co-occurrence of diabetes and hopelessness predicts adverse prognosis following percutaneous coronary intervention. J Behav Med (2009) 0.75
Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease. Korean Circ J (2017) 0.75
[ESC/EASD joint guidelines on diabetes and cardiovascular diseases]. Herz (2009) 0.75
[Experiences collected in more than 2,300 diabetics undergoing coronary artery bypass grafting: patients with a specific risk profile]. Clin Res Cardiol (2006) 0.75
[Glucose metabolism]. Z Kardiol (2005) 0.75